Aldosterone stimulation by angiotensin II: Influence of gender, plasma renin, and familial resemblance

Hypertension

Volumn 35, Issue 3, 2000, Pages 710-716

  Giacché, Mara ^a   Vuagnat, Albert ^a   Hunt, Steven C ^b   Hopkins, Paul N ^b   Fisher, Naomi D L ^c   Azizi, Michel ^a   Corvol, Pierre ^a   Williams, Gordon H ^c   Jeunemaitre, Xavier ^a  

^a l'alimentation et l'Environnement   (France)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Age; Aldosterone; Gender; Genetics; Hypertension, arterial; Renin angiotensin system

Indexed keywords

ALDOSTERONE; ANGIOTENSIN;

ADULT; ARTICLE; FAMILIAL DISEASE; FEMALE; GENDER; HORMONE RESPONSE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PLASMA RENIN ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; QUANTITATIVE TRAIT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEX DIFFERENCE;

EID: 0034023170     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.35.3.710     Document Type: Article

References (25)

1. Corvol P, Persu A, Gimenez-Roqueplo AP, Jeunemaitre X. Seven lessons from two candidate genes in human essential hypertension. Hypertension. 1999;33:1324-1331.
2. McCarthy MI, Kruglyak L, Lander ES. Sib-pair collection strategies for complex diseases. Genet Epidemiol. 1998;15:317-340.
3. Luft FC. Molecular genetics of human hypertension. J Hypertens. 1998; 16:1871-1878.
4. Williams GH, Hollenberg NK, Hopkins PM, Jeunemaitre X. The role of intermediate phenotypes in essential hypertension: non-modulation as a model. Endocr Res. 1996;22:675-680.
5. Williams GH, Dluhy RG, Lifton RP, Moore TJ, Gleason R, Williams RR, Hunt SC, Hopkins PN, Hollenberg NK. Non-modulation as an intermediate phenotype in essential hypertension. Hypertension. 1992;20: 788-796.
6. Rystedt L, Williams GH, Hollenberg NK. The renal and endocrine response to saline infusion in essential hypertension. Hypertension. 1986; 8:217-222.
7. Lifton RP, Hopkins PN, Williams RR, Hollenberg NK, Williams GH, Dluhy RG. Evidence for heritability of non-modulating essential hypertension. Hypertension. 1989;13:884-889.
8. Emanuel R, Cain JP, Williams GH. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. J Lab Clin Med. 1973;81:632-640.
9. Donner A, Eliasgaw M. Methodology for inferences concerning familial correlations: a review. J Clin Epidemiol. 1991;44:449-455.
10. S.A.G.E. Statistical Analysis for Genetic Epidemiology, release 2.2. Computer program package available from the Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio, 1994.
11. Fisher NDL, Ferri C, Bellini C, Santucci A, Gleason R, Williams GH, Hollenberg NK, Seely EW. Age, gender, and nonmodulation: a sexual dimorphism in essential hypertension. Hypertension. 1997;29:980-985.
12. Miller JA, Anacta LA, Cattran DC. Impact of gender on the renal response to angiotensin II. Kidney Int. 1999;55:278-285.
13. Gilligan DM, Badar DM, Panza JM, Quyyumi AA, Cannon RO III. Acute vascular effects of estrogen in postmenopausal women. Circulation. 1994;90:786-791.
14. Plouin PF, Chatellier G, Guyenne TT, Vincent N, Corvol P. Recent advances in the clinical study of the renin angiotensin system: reference values and conditions of validity. Presse Med. 1989;18:917-921.
15. Danser AHJ, Derkx FHM, Schalekamp MADH, Hense HW, Riegger GAJ, Schunkert H. Determinants of interindividual variation of renin and prorenin concentrations: evidence of a sexual dimorphism of (pro)renin levels in humans. J Hypertens. 1998;16:853-862.
16. Fisher ND, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in low-renin essential hypertension. Hypertension. 1999;34:388-394.
17. Warnock DG. Low-renin and nonmodulating essential hypertension. Hypertension. 1999;34:395-397.
18. Mann JF, Leidig M, Ritz E. Human angiotensin II receptors are regulated by angiotensin II. Clin Exp Hypertens (A). 1988;10:151-168.
19. Llorens-Cortes C, Greenberg B, Huang H, Corvol P. Tissular expression and regulation of type 1 angiotensin II receptor subtypes by quantitative reverse transcriptase-polymerase chain reaction analysis. Hypertension. 1998;24:538-548.
20. Carriere PD, De Lean A, Gutkowska J, Genest J, Cantin M. Chronic estradiol treatment decreases angiotensin II receptor density in the anterior pituitary gland and adrenal cortex but not in the mesenteric artery. Neuroendocrinology. 1986;43:49-56.
21. Hollenberg NK, Moore T, Shoback D, Redgrave J, Rabinowe S, Williams GH. Abnormal renal sodium handling in essential hypertension: relation to failure of renal and adrenal modulation of responses to Ang II. Am J Med. 1986;81:412-418.
22. Beretta-Piccoli C, Pusterla C, Stadler P, Weidmann P. Blunted aldosterone responsiveness to angiotensin II in normotensive subjects with familial predisposition to essential hypertension. J Hypertens. 1988;6: 57-61.
23. Widgren BR, Herlitz H, Aurell M, Berglund G, Wikstrand J, Anderson OK. Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens. 1992;5:167-164.
24. Kardia SLR, Sing CF, Turner ST. The response of renal plasma flow to angiotensin II infusion in a population based-sample and its association with the parental history of essential hypertension. J Hypertens. 1997;15: 483-493.
25. Heiba IM, Elston Rc, Klein BEK, Klein R. Sibling correlations and segregation analysis of age-related maculopathy: the Beaver Dam Eye Study. Genet Epidemiol. 1994;11:51-67.